Staci Kephart
Physician Assistant · Coalport, PANPI 1619225828
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 201 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,164 and has fallen 61.5% since, to $448 in 2025. Among physician assistant clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 201 payments — averaging $16.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$458
- Pfizer$402
- Novo Nordisk$361
- Lilly USA, LLC$306
- Amgen$275
- Amarin Pharma, Inc.$212
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,18697%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 31 | $458 |
| Pfizer | 25 | $402 |
| Novo Nordisk | 26 | $361 |
| Lilly USA, LLC | 21 | $306 |
| Amgen | 16 | $275 |
| Amarin Pharma, Inc. | 13 | $212 |
| Astellas Pharma US Inc | 6 | $177 |
| Johnson & Johnson | 8 | $141 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $138 |
| GSK | 6 | $90 |
| Merck | 5 | $88 |
| Boston Scientific | 3 | $84 |
| Exact Sciences | 4 | $74 |
| Biohaven Pharmaceuticals, Inc. | 3 | $62 |
| AstraZeneca | 4 | $61 |
| Sanofi Pasteur Inc. | 4 | $54 |
| E.r. Squibb & Sons, L.L.C. | 3 | $48 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $45 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $45 |
| Ardelyx, Inc. | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Abbott | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Hologic Sales And Service, LLC | 1 | $13 |
| Gilead | 1 | $13 |
How this compares
$3,286 in reported general payments places this provider in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 85 | $88,592 |
| JardianceEmpagliflozin | 53 | $43,366 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 56 | $38,812 |
| TrulicityDulaglutide | 31 | $29,788 |
| EliquisApixaban | 30 | $27,310 |
| TradjentaLinagliptin | 37 | $26,785 |
| MounjaroTirzepatide | 20 | $20,341 |
| XareltoRivaroxaban | 21 | $16,121 |
| FarxigaDapagliflozin Propanediol | 25 | $14,393 |
| JanuviaSitagliptin Phosphate | 24 | $13,369 |
| Breo ElliptaFluticasone/Vilanterol | 33 | $12,913 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 58 | $7,809 |
| MyrbetriqMirabegron | 13 | $5,884 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $5,350 |
| Atorvastatin Calcium | 289 | $3,133 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $361 | $88,59285 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $90 | $57,075101 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $306 | $50,12951 claims |
| PfizerEliquis | $402 | $27,31030 claims |
| Johnson & JohnsonXarelto | $141 | $16,12121 claims |
| AstraZenecaFarxiga | $61 | $14,39325 claims |
| MerckJanuvia | $88 | $13,36924 claims |
| Astellas Pharma US IncMyrbetriq | $177 | $5,88413 claims |
| AbbVieSynthroid | $458 | $1,50543 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.
Other physician assistant in Coalport
- Erin CrownState College$1.2M
- Tricia BootsCranberry Twp$313K
- Melissa FerrariPhiladelphia$223K
- Jason OberdickWexford$206K
- Justine RobertsMurrysville$173K
- Allison BoydErie$163K
- Joshua TrbovichWashington$144K
- Daniel TelegaErie$124K
- Jeffrey CameronWashington$89K
- Dorissa BrivchikPittsburgh$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.